BioCentury | Apr 2, 2009
Distillery Therapeutics

Indication: Endocrine disease

...of the lead compound in animal models of contraception or ovarian cancer. Merck KGaA markets Ovidrel...
BioCentury | Oct 13, 2003
Clinical News

Ovidrel choriogonadotropin alfa regulatory update

...The FDA granted marketing approval for Ovidrel PreFilled Syringe, a recombinant human chorionic gonadotropin (hCG...
...to treat infertility by subcutaneous injection. Serono SA (SWX:SEO; SRA), Geneva, Switzerland Product: Ovidrel choriogonadotropin alfa...
BioCentury | Oct 9, 2000
Clinical News

Ovidrel choriogonadotropin alfa regulatory update

...Ovidrel also is under review in Europe. Serono S.A. (SWX:SEO; SRA), Geneva, Switzerland Product: Ovidrel choriogonadotropin alfa...
BioCentury | Oct 2, 2000
Company News

Serono gets U.S. approval for Ovidrel

...Serono (SWX:SEO; SRA) received FDA marketing approval for Ovidrel choriogonadotropin injection for the treatment of infertility...
Items per page:
1 - 4 of 4